Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Initiates Coverage On EQRx with Outperform Rating

Cowen & Co. analyst Steve Scala initiates coverage on EQRx (NASDAQ:EQRX) with a Outperform rating.

byBenzinga Newsdesk

April 22, 2022

1 minute read

Cowen & Co. analyst Steve Scala initiates coverage on EQRx (NASDAQ:EQRX) with a Outperform rating.

Morgan Stanley Maintains Underweight on Omnicom Group, Lowers Price Target to $76

By Benzinga Newsdesk

Today, 6:49 AM

Morgan Stanley analyst Benjamin Swinburne maintains Omnicom Group (NYSE:OMC) with a Underweight and lowers the price target from $79 to $76.

OMC

Analyst Ratings

What 7 Analyst Ratings Have To Say About ACADIA Pharmaceuticals

By Benzinga Insights

Today, 6:49 AM

Over the past 3 months, 7 analysts have published their opinion on ACADIA Pharmaceuticals (NASDAQ:ACAD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

ACAD

Donald Trump Won’t Be Allowed Back On Facebook Until This Date At The Earliest

By Chris Katje

Today, 6:49 AM

Former President Donald Trump could be welcomed back to social media platform Twitter Inc (NYSE: TWTR) if the acquisition by Tesla Inc (NASDAQ: TSLA) CEO Elon Musk is completed.

DKNG